METTL1 and intrahepatic cholangiocarcinoma: Liu et.al recently revealed that METTL1-mediated m7G modification significantly regulates PMN-MDSCs accumulation in the immune microenvironment and intrahepatic cholangiocarcinoma progression through targeting CXCL8 in humans and Cxcl5 in mice 34.